Vijay Nambi, MD
Enriched profileProfessor of Medicine-Cardiology · Baylor College of Medicine
Vijay Nambi is Professor of Medicine-Cardiology at Baylor College of Medicine. OpenAlex indexes 655 publications with 16,729 citations (h-index 63); ClinicalTrials.gov lists 1 registered study with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Cardiovascular Disease profiles in the findmyKOL directory.
Data verified 11 Oct 2026
Overview
Updated 14 Oct 2026
Vijay Nambi, M.D., is Professor of Medicine-Cardiology at Baylor College of Medicine. The public record shows 655 publications with 16,729 citations (h-index 63), centered on Lipoproteins and Cardiovascular Health, Heart Failure Treatment and Management, Diabetes, Cardiovascular Risks, and Lipoproteins. It also documents an investigator role on 1 registered clinical trials, industry payments reported by 3 companies, 2 NIH-funded awards (2009–2019).
- Most recent indexed publication: 2026 · Arteriosclerosis, thrombosis, and vascular biology
- Top research focus: Lipoproteins and Cardiovascular Health
- 1 registered trials on ClinicalTrials.gov
- Open Payments reporting from 3 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 22 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 227.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 1 registered study on ClinicalTrials.gov. The most recent:
- Biomarker Guided Therapies in Stage A/B Heart Failure
Sponsor: VA Office of Research and Development
Industry payments
Updated 14 Oct 2026
3 companies reported payments to CMS in program years 2021–2024. These are public disclosures, not judgments. The latest:
- iRhythm Technologies, Inc.Program year202411 payments
- iRhythm Technologies, Inc.Program year20231 payment
- Lantheus Medical Imaging, Inc.Program year20221 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
100%PCSK9 Inhibitor52%Repatha Sureclick69%Praluent Pen31%Part D<11 patientsCholesterol absorption inhibitor27.6%Ezetimibe100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
2 NIH research awards on record, funded 2009–2019 per NIH RePORTER. The latest:
- Biomarker guided therapies in Stage A/B Heart Failure
Michael E Debakey Va Medical Center
FY2019I01CX001112 - Biomarker guided therapies in Stage A/B Heart Failure
Michael E Debakey Va Medical Center
FY2018I01CX001112 - Biomarker guided therapies in Stage A/B Heart Failure
Michael E Debakey Va Medical Center
FY2017I01CX001112
Congress activity
Updated 14 Oct 2026
4 congress contributions (2019–2024) across ADA, ENDO per OpenAlex. The most recent:
- 246-OR: Association of Erythritol and Erythronate with Cardiovascular Outcomes and Death
ADA Scientific Sessions
ADA2024Co-authorOral - 1231-P: Influence of Diabetes on the Progression of Preclinical Stage B Heart Failure Phenotypes to Heart Failure
ADA Scientific Sessions
ADA2023Co-authorPoster
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Metabolites Associated With Long-Term Risk of Peripheral Artery Disease: The ARIC Study.
Arteriosclerosis, thrombosis, and vascular biology
Article2026 - Targeting Lipoprotein(a): A New Era in Cardiovascular Disease Prevention.
Methodist DeBakey cardiovascular journal
Review2026 - "U'r-in(e)!- Urine-albumin-creatinine ratio-the old kid on a new block!
European journal of preventive cardiology
Comment2026 - Heart Failure and Death in Older Adults With Elevated Cardiac Biomarkers But Without Risk Factors: The Atherosclerosis Risk in Communities Study.
Journal of the American Heart Association
Article2025
Most-cited works
by citation count (OpenAlex)- 01Prognostic Value of Myeloperoxidase in Patients with Chest PainArticle1,073 citations2003
- 02
- 03
- 04
- 05
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- Board certified
Internal Medicine (American Board of Internal Medicine)
- Board certified
Cardiovascular Disease (American Board of Internal Medicine)
Editorial & leadership roles
journal and society appointments- Program Director
Lipids and Lipoprotein Fellowship, Baylor College of Medicine
- Officer
Southwest Lipid Association
- Chair
Vascular Council, American Society of Echocardiography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org ↗ - Member
Education Committee, American Society of Echocardiography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org ↗ - Topic coordinator
prevention sessions, American College of Cardiology Scientific Sessions
- Member
American College of Cardiology
Secondary affiliations
appointments beyond the home institution- Staff Cardiologist
Michael E. DeBakey Veterans Affairs Medical Center, Houston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiometabolichealth.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Christie Ballantyne, MD
Baylor College of Medicine
Biykem Bozkurt, MD
Baylor College of Medicine
Garabed Eknoyan, MD
Baylor College of Medicine
Sankar Navaneethan, MD
Baylor College of Medicine
Paul Ridker, MD
Brigham and Women's Hospital
Edward Giovannucci, MD, ScD, MPH
Harvard T.H. Chan School of Public Health
Stephen Chanock, MD
National Cancer Institute (NCI)
Wei Zheng, MD, PhD, MPH
Vanderbilt University Medical Center